78 related articles for article (PubMed ID: 15862947)
1. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
St-Laurent V; Sanchez M; Charbonneau C; Tremblay A
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
[TBL] [Abstract][Full Text] [Related]
2. Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer.
Naderi A; Meyer M; Dowhan DH
Neoplasia; 2012 Apr; 14(4):283-96. PubMed ID: 22577344
[TBL] [Abstract][Full Text] [Related]
3. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.
Biswas DK; Shi Q; Baily S; Strickland I; Ghosh S; Pardee AB; Iglehart JD
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10137-42. PubMed ID: 15220474
[TBL] [Abstract][Full Text] [Related]
4. WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer.
Liu T; Zhao M; Peng L; Chen J; Xing P; Gao P; Chen L; Qiao X; Wang Z; Di J; Qu H; Jiang B; Su X
Cell Death Dis; 2023 Jul; 14(7):425. PubMed ID: 37443102
[TBL] [Abstract][Full Text] [Related]
5. Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization.
Magi S; Iwamoto K; Yumoto N; Hiroshima M; Nagashima T; Ohki R; Garcia-Munoz A; Volinsky N; Von Kriegsheim A; Sako Y; Takahashi K; Kimura S; Kholodenko BN; Okada-Hatakeyama M
J Biol Chem; 2018 Feb; 293(6):2206-2218. PubMed ID: 29233889
[TBL] [Abstract][Full Text] [Related]
6. The ERBB2 Exonic Variant Pro1170Ala Modulates Mitogen-Activated Protein Kinase Signaling Cascades and Associates with Allergic Asthma.
Sio YY; Gan WL; Ng WS; Matta SA; Say YH; Teh KF; Wong YR; Rawanan Shah SM; Reginald K; Chew FT
Int Arch Allergy Immunol; 2023; 184(10):1010-1021. PubMed ID: 37336194
[TBL] [Abstract][Full Text] [Related]
7. ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function.
Bado I; Pham E; Soibam B; Nikolos F; Gustafsson JÅ; Thomas C
Oncotarget; 2018 Apr; 9(32):22509-22522. PubMed ID: 29854295
[TBL] [Abstract][Full Text] [Related]
8. ERβ-activated LINC01018 promotes endometriosis development by regulating the CDC25C/CDK1/CyclinB1 pathway.
Lu R; Zhu J; Li X; Zeng C; Huang Y; Peng C; Zhou Y; Xue Q
J Genet Genomics; 2024 Jan; ():. PubMed ID: 38224945
[TBL] [Abstract][Full Text] [Related]
9. Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition.
Ogden S; Carys K; Ahmed I; Bruce J; Sharrocks AD
Oncogene; 2022 Oct; 41(43):4808-4822. PubMed ID: 36153371
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta expression and role in cancers.
Monteiro FL; Stepanauskaite L; Archer A; Williams C
J Steroid Biochem Mol Biol; 2024 Apr; 242():106526. PubMed ID: 38657699
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives.
Vandewalle J; Van der Auwera BJ; Amin H; Quartier E; Desouter AK; Tenoutasse S; Gillard P; De Block C; Keymeulen B; Gorus FK; Van de Casteele M;
Diabetologia; 2021 Nov; 64(11):2511-2516. PubMed ID: 34448034
[TBL] [Abstract][Full Text] [Related]
12. A Phosphotyrosine Switch in Estrogen Receptor β Is Required for Mouse Ovarian Function.
Yuan B; Yang J; Dubeau L; Hu Y; Li R
Front Cell Dev Biol; 2021; 9():649087. PubMed ID: 33898441
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.
Lee L; Ramos-Alvarez I; Moody TW; Mantey SA; Jensen RT
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118625. PubMed ID: 31862538
[TBL] [Abstract][Full Text] [Related]
14. The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.
Dittrich A; Gautrey H; Browell D; Tyson-Capper A
J Mammary Gland Biol Neoplasia; 2014 Dec; 19(3-4):253-70. PubMed ID: 25544707
[TBL] [Abstract][Full Text] [Related]
15. Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitor.
Kugel CH; Hartsough EJ; Davies MA; Setiady YY; Aplin AE
Cancer Res; 2014 Aug; 74(15):4122-32. PubMed ID: 25035390
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease.
Jannot AS; Pelet A; Henrion-Caude A; Chaoui A; Masse-Morel M; Arnold S; Sanlaville D; Ceccherini I; Borrego S; Hofstra RM; Munnich A; Bondurand N; Chakravarti A; Clerget-Darpoux F; Amiel J; Lyonnet S
PLoS One; 2013; 8(5):e62519. PubMed ID: 23671607
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.
Antoon JW; Nitzchke AM; Martin EC; Rhodes LV; Nam S; Wadsworth S; Salvo VA; Elliott S; Collins-Burow B; Nephew KP; Burow ME
Int J Oncol; 2013 Apr; 42(4):1139-50. PubMed ID: 23403951
[TBL] [Abstract][Full Text] [Related]
18. Identification of estrogen receptor β as a SUMO-1 target reveals a novel phosphorylated sumoylation motif and regulation by glycogen synthase kinase 3β.
Picard N; Caron V; Bilodeau S; Sanchez M; Mascle X; Aubry M; Tremblay A
Mol Cell Biol; 2012 Jul; 32(14):2709-21. PubMed ID: 22586270
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-beta and breast cancer: translating biology into clinical practice.
Leung YK; Lee MT; Lam HM; Tarapore P; Ho SM
Steroids; 2012 Jun; 77(7):727-37. PubMed ID: 22465878
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]